Abstract:Objective: Endothelial nitric oxide synthase (eNOS) may play an important role in the regulation of tumor blood flow and vascular permeability. However, there have been no reports describing alterations of eNOS expression in relation to malignant progression in human astrocytic tumors. We immunohistochemically studied the relationship between eNOS expression in tumor vasculature and malignancy in supratentorial astrocytic tumors. Methods: Tissue samples were obtained from 12 patients with low-grade astrocytomas, 10 with anaplastic astrocytomas, and 17 with glioblastomas. Normal brain tissue samples were obtained from four patients with other brain diseases. Immunohistochemical staining was performed using the avidin-biotin complex method, with polyclonal anti-eNOS antibody, and the levels of eNOS expression in endothelial cells were evaluated as slight, moderate, or intense on the basis of eNOS immunoreactivity. The proliferative potential was assessed as the MIB-1 staining index for tumor cells. Results: The expression of eNOS was slight in all specimens of normal brain tissue, slight in 7 and moderate in 5 specimens of low-grade astrocytoma, slight in 2, moderate in 6, and intense in 2 specimens of anaplastic astrocytoma, and moderate in 5 and intense in 12 specimens of glioblastoma. The MIB-1 staining index (mean+/-standard deviation) was 0.2+/-0.2% for normal specimens, 1.8+/-0.6% for low-grade astrocytomas, 9.6+/-6.9% for anaplastic astrocytomas, and 18.5+/-7.7% for glioblastomas. The MIB-1 staining indices for slight, moderate, and intense eNOS expression were 2.0+/-2.3%, 10.8+/-9.8%, and 16.9+/-7.7%, respectively. Conclusion: Expression of eNOS in tumor vessels was significantly correlated with histological grade and proliferative potential. These findings suggest that astrocytic tumor vessels possess higher activity for nitric oxide production than do normal vessels.

Expression of Enos and VEGF in Association with Angiogenesis of Human Astrocytoma

Expression of Endothelial Nitric Oxide Synthase and Vascular Endothelial Growth Factor in Association with Neovascularization in Human Primary Astrocytoma.

Expression and significance of vascuIar endothelial growth factor and VIII-R Ag in human brain glioma

Expression and significance of vascuIar endothelial growth factor and Ⅷ-R Ag in human brain glioma

Role of Urokinase-type Plasminogen Activator and Vascular Endothelial Growth Factor and the Correlation in Human Astrocytomas Invasion

Expression and Biologic Significance of Vascular Endothelial Growth Factor (VEGF) in Human Meningiomas

Expression of cyclooxygenase-2 and VEGF in human glioma and its role

Significance of Expression of Endothelial Nitric Oxide Synthase and Microvessel Density in Astrocytoma

Expressions of vascular endothelial growth factor gene protein in astrocytoma and its clinical significance

[Expression of Vascular Endothelial Growth Factor in Brain Astrocytoma and Its Clinical Evaluation].

The Expression of CD44s and Mib-1 in Astrocytomas and Their Clinical Significance

Clinical Implications of VEGF and Ki-67 Expression in Astrocytic Tumor Patients

Expressions of AQP-1 and VEGF in Astrocytomas and Their Significance

Relationship Between Expression of Matrix Metalloproteinase-2, Matrix Metalloproteinase-9 Mrna and Angiogenesis in Astrocytomas

The expressions of VEGF and COX- 2 protein in astrocytoma

P53 and Vascular Endothelial Growth Factor Expression in Astrocytoma and Their Relation to Angiogenesis

Endothelial nitric oxide synthase expression in tumor vasculature is correlated with malignancy in human supratentorial astrocytic tumors

Neuritin expression and its relation with proliferation, apoptosis, and angiogenesis in human astrocytoma

Expression of FAK and Pyk2 in Human Astrocytic Tumors and its Relationship with Angiogenesis

Study on the expression of AEG-1 and its clinical significance in the astrocytomas of different grades

Detection of Microvessel Density and Expression of Vascular Endothelial Growth Factor in Cerebral Astrocytoma Tissue